Showing results (361-370 of 793) with videos related to

Sort By:
Pageof 80
British Journal of Haematology|January 11, 2005
Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical applicationToshiaki Hayashi, Teru Hideshima, Masaharu Akiyama, et al.
Bone Marrow Transplantation|March 17, 2022
Impact of maintenance therapy post autologous stem cell transplantation for multiple myeloma in early and delayed transplantDhauna Karam, Morie Gertz, Martha Lacy, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|February 15, 2017
Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 ConferenceUday Yanamandra, Navin Khattry, Shaji Kumar, et al.
British Journal of Haematology|October 9, 2003
Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myelomaMichael A Thompson, Thomas E Witzig, Shaji Kumar, et al.
European Journal of Haematology|May 19, 2010
Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myelomaFrancesca Gay, S Vincent Rajkumar, Patrizia Falco, et al.
Hematological Oncology|September 23, 2023
Venetoclax in biomarker-selected multiple myeloma patients: Impact of exposure on clinical efficacy and safetyMohamed Badawi, Sheryl Coppola, Doerthe Eckert, et al.
Targeted Oncology|December 13, 2016
Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)Joleen M Hubbard, Michelle R Mahoney, William S Loui, et al.
Mayo Clinic Proceedings|April 17, 2018
Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic ReviewRobert A Kyle, Dirk R Larson, Ellen D McPhail, et al.
Leukemia|May 17, 2019
Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m2 vs. twice-weekly 27 mg/m2 carfilzomib (randomized A.R.R.O.W. study)Philippe Moreau, Shaji Kumar, Ralph Boccia, et al.
Archives of Dermatology|October 19, 2005
Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantationMartha Q Lacy, William J Hogan, Morie A Gertz, et al.
Pageof 80